{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:43:54Z","timestamp":1794033834729,"version":"4.8.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myxomatous mitral valve disease (MMVD), the most common naturally-occurring heart disease in dogs, is associated with alterations in energy metabolism, oxidative stress and inflammation. Energy deprivation plays a causal role in the development of heart failure. This study was designed to determine if a cardiac protection blend (CPB) of nutrients containing medium-chain triglycerides as an alternative energy source, fish oil to reduce inflammation, antioxidants, and other key nutrients important to cardiac health and function could slow or prevent MMVD progression. Nineteen dogs with early stage MMVD and 17 breed-, age-, and sex-matched healthy dogs were enrolled for a 6-month blinded, placebo-controlled study. Dogs in each cardiac health group were randomly assigned to either control diet (CON) or CPB-supplemented diet. Echocardiography was performed at baseline, 3\u2009months and 6\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No changes were found in healthy dogs. While MMVD-CON dogs had an average 10% increase over baseline in left atrial diameter (LAD) and left atrial to aortic root ratio (LA\/Ao) at 6\u2009months, MMVD-CPB dogs showed 3% decreases, resulting significant diet by time interactions (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.037,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005, respectively). More MMVD-CON dogs progressed from stage B1 to B2 during the study. A positive correlation was found between 6-month changes in LAD and blood pressures in MMVD-CPB dogs (systolic:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.050, diastolic:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.035) but not MMVD-CON dogs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results demonstrated efficacy of CPB-based dietary intervention in reducing LA size and mitral regurgitation, and in slowing or preventing the progression of early MMVD in dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-019-2169-1","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T12:03:47Z","timestamp":1574856227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs"],"prefix":"10.1186","volume":"15","author":[{"given":"Qinghong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Langenfeld-McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany Vester","family":"Boler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy P.","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"6","key":"2169_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","volume":"23","author":"C Atkins","year":"2009","unstructured":"Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009;23(6):1142\u201350.","journal-title":"J Vet Intern Med"},{"issue":"5","key":"2169_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","volume":"22","author":"J Haggstrom","year":"2008","unstructured":"Haggstrom J, Boswood A, O'Grady M, Jons O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124\u201335.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"2169_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358.","journal-title":"Physiol Rev"},{"issue":"3","key":"2169_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0005-2760(94)00082-4","volume":"1213","author":"GD Lopaschuk","year":"1994","unstructured":"Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1994;1213(3):263\u201376.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2169_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0008-6363(99)00263-1","volume":"45","author":"GJ van der Vusse","year":"2000","unstructured":"van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45(2):279\u201393.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"2169_CR6","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart--an engine out of fuel. N Engl J Med. 2007;356(11):1140\u201351.","journal-title":"N Engl J Med"},{"issue":"19","key":"2169_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1101\/gad.269894.115","volume":"29","author":"GW Dorn 2nd","year":"2015","unstructured":"Dorn GW 2nd, Vega RB, Kelly DP. Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 2015;29(19):1981\u201391.","journal-title":"Genes Dev"},{"issue":"6","key":"2169_CR8","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","volume":"7","author":"L Lai","year":"2014","unstructured":"Lai L, Leone TC, Keller MP, Martin OJ, Broman AT, Nigro J, Kapoor K, Koves TR, Stevens R, Ilkayeva OR, et al. Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach. Circ Heart Fail. 2014;7(6):1022\u201331.","journal-title":"Circ Heart Fail"},{"issue":"7","key":"2169_CR9","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","volume":"96","author":"S Neubauer","year":"1997","unstructured":"Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation. 1997;96(7):2190\u20136.","journal-title":"Circulation"},{"issue":"4","key":"2169_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11357-016-9933-y","volume":"38","author":"B Martin-Fernandez","year":"2016","unstructured":"Martin-Fernandez B, Gredilla R. Mitochondria and oxidative stress in heart aging. Age (Dordr). 2016;38(4):225\u201338.","journal-title":"Age (Dordr)"},{"issue":"2","key":"2169_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/cvr\/cvr038","volume":"90","author":"V Lionetti","year":"2011","unstructured":"Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res. 2011;90(2):202\u20139.","journal-title":"Cardiovasc Res"},{"key":"2169_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.freeradbiomed.2018.09.019","volume":"129","author":"LA Kiyuna","year":"2018","unstructured":"Kiyuna LA, Albuquerque RPE, Chen CH, Mochly-Rosen D, Ferreira JCB. Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities. Free Radic Biol Med. 2018;129:155\u201368.","journal-title":"Free Radic Biol Med"},{"key":"2169_CR13","doi-asserted-by":"publisher","first-page":"514623","DOI":"10.4061\/2011\/514623","volume":"2011","author":"FJ Pashkow","year":"2011","unstructured":"Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and\/or prevention? Int J Inflam. 2011;2011:514623.","journal-title":"Int J Inflam"},{"issue":"8","key":"2169_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/omi.2015.0057","volume":"19","author":"Q Li","year":"2015","unstructured":"Li Q, Freeman LM, Rush JE, Huggins GS, Kennedy AD, Labuda JA, Laflamme DP, Hannah SS. Veterinary medicine and multi-Omics research for future nutrition targets: metabolomics and Transcriptomics of the common degenerative mitral valve disease in dogs. OMICS. 2015;19(8):461\u201370.","journal-title":"OMICS"},{"key":"2169_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tvjl.2016.03.002","volume":"211","author":"A Mavropoulou","year":"2016","unstructured":"Mavropoulou A, Guazzetti S, Borghetti P, De Angelis E, Quintavalla C. Cytokine expression in peripheral blood mononuclear cells of dogs with mitral valve disease. Vet J. 2016;211:45\u201351.","journal-title":"Vet J"},{"issue":"8","key":"2169_CR16","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2460\/ajvr.67.8.1307","volume":"67","author":"MA Oyama","year":"2006","unstructured":"Oyama MA, Chittur SV. Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease. Am J Vet Res. 2006;67(8):1307\u201318.","journal-title":"Am J Vet Res"},{"key":"2169_CR17","doi-asserted-by":"crossref","unstructured":"Saifudeen I, Subhadra L, Konnottil R, Nair RR. Metabolic modulation by medium-chain triglycerides reduces oxidative stress and ameliorates CD36-mediated cardiac remodeling in spontaneously hypertensive rat in the initial and established stages of hypertrophy. J Card Fail. 2016.","DOI":"10.1016\/j.cardfail.2016.08.001"},{"issue":"2","key":"2169_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10557-008-6084-0","volume":"22","author":"F Labarthe","year":"2008","unstructured":"Labarthe F, Gelinas R, Des Rosiers C. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc Drugs Ther. 2008;22(2):97\u2013106.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Supplementum 5","key":"2169_CR19","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.33549\/physiolres.933538","volume":"65","author":"M Cedikova","year":"2016","unstructured":"Cedikova M, Pitule P, Kripnerova M, Markova M, Kuncova J. Multiple roles of mitochondria in aging processes. Physiol Res. 2016;65(Supplementum 5):S519\u201331.","journal-title":"Physiol Res"},{"issue":"6","key":"2169_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cvsm.2006.08.010","volume":"36","author":"SL Sanderson","year":"2006","unstructured":"Sanderson SL. Taurine and carnitine in canine cardiomyopathy. Vet Clin North Am Small Anim Pract. 2006;36(6):1325\u201343 vii-viii.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"12","key":"2169_CR21","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1194\/jlr.M040451","volume":"54","author":"MK Montgomery","year":"2013","unstructured":"Montgomery MK, Osborne B, Brown SH, Small L, Mitchell TW, Cooney GJ, Turner N. Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle. J Lipid Res. 2013;54(12):3322\u201333.","journal-title":"J Lipid Res"},{"key":"2169_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lfs.2017.12.015","volume":"194","author":"ZY Wang","year":"2018","unstructured":"Wang ZY, Liu YY, Liu GH, Lu HB. Mao CY: l-Carnitine and heart disease. Life Sci. 2018;194:88\u201397.","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"2169_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1423-0127-17-S1-S2","volume":"17","author":"Stephen W Schaffer","year":"2010","unstructured":"Schaffer SW, Jong CJ, Ramila KC, Azuma J: Physiological roles of taurine in heart and muscle. J Biomed Sci 2010, 17 Suppl 1:S2.","journal-title":"Journal of Biomedical Science"},{"issue":"1","key":"2169_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0891-5849(99)00224-5","volume":"28","author":"WA Pryor","year":"2000","unstructured":"Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med. 2000;28(1):141\u201364.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2169_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/iub.1988","volume":"71","author":"M Birringer","year":"2019","unstructured":"Birringer M, Lorkowski S. Vitamin E: regulatory role of metabolites. IUBMB Life. 2019;71(4):479\u201386.","journal-title":"IUBMB Life"},{"issue":"4","key":"2169_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/iub.2020","volume":"71","author":"E Sozen","year":"2019","unstructured":"Sozen E, Demirel T, Ozer NK. Vitamin E: regulatory role in the cardiovascular system. IUBMB Life. 2019;71(4):507\u201315.","journal-title":"IUBMB Life"},{"issue":"9","key":"2169_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1748-5827.2010.00968.x","volume":"51","author":"LM Freeman","year":"2010","unstructured":"Freeman LM. Beneficial effects of omega-3 fatty acids in cardiovascular disease. J Small Anim Pract. 2010;51(9):462\u201370.","journal-title":"J Small Anim Pract"},{"issue":"5","key":"2169_CR28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","volume":"68","author":"R Wall","year":"2010","unstructured":"Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 2010;68(5):280\u20139.","journal-title":"Nutr Rev"},{"issue":"4","key":"2169_CR29","first-page":"315","volume":"14","author":"RH Schwinger","year":"1992","unstructured":"Schwinger RH, Erdmann E. Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol. 1992;14(4):315\u201325.","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"2169_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3945\/ajcn.112.053132","volume":"98","author":"LC Del Gobbo","year":"2013","unstructured":"Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98(1):160\u201373.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"2169_CR31","doi-asserted-by":"publisher","first-page":"R1102","DOI":"10.1152\/ajpregu.00268.2013","volume":"305","author":"IT Mak","year":"2013","unstructured":"Mak IT, Kramer JH, Chen X, Chmielinska JJ, Spurney CF, Weglicki WB. Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats. Am J Physiol Regul Integr Comp Physiol. 2013;305(10):R1102\u201311.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"4","key":"2169_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10863-016-9666-8","volume":"48","author":"N Ozturk","year":"2016","unstructured":"Ozturk N, Olgar Y, Aslan M, Ozdemir S. Effects of magnesium supplementation on electrophysiological remodeling of cardiac myocytes in L-NAME induced hypertensive rats. J Bioenerg Biomembr. 2016;48(4):425\u201336.","journal-title":"J Bioenerg Biomembr"},{"issue":"6","key":"2169_CR33","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3945\/ajcn.112.054114","volume":"97","author":"MM Joosten","year":"2013","unstructured":"Joosten MM, Gansevoort RT, Mukamal KJ, van der Harst P, Geleijnse JM, Feskens EJ, Navis G, Bakker SJ, Group PS. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97(6):1299\u2013306.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2169_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057720","volume":"8","author":"X Qu","year":"2013","unstructured":"Qu X, Jin F, Hao Y, Li H, Tang T, Wang H, Yan W, Dai K. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One. 2013;8(3):e57720.","journal-title":"PLoS One"},{"key":"2169_CR35","doi-asserted-by":"publisher","first-page":"308190","DOI":"10.1155\/2015\/308190","volume":"2015","author":"AP Silva","year":"2015","unstructured":"Silva AP, Gundlach K, Buchel J, Jeronimo T, Fragoso A, Silva C, Guilherme P, Santos N, Faisca M, Neves P. Low magnesium levels and FGF-23 Dysregulation predict mitral valve calcification as well as intima media thickness in Predialysis diabetic patients. Int J Endocrinol. 2015;2015:308190.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"2169_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0002-9149(96)00865-X","volume":"79","author":"B Lichodziejewska","year":"1997","unstructured":"Lichodziejewska B, Klos J, Rezler J, Grudzka K, Dluzniewska M, Budaj A, Ceremuzynski L. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol. 1997;79(6):768\u201372.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2169_CR37","first-page":"35","volume":"18","author":"W Bobkowski","year":"2005","unstructured":"Bobkowski W, Nowak A, Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapse. Magnes Res. 2005;18(1):35\u201352.","journal-title":"Magnes Res"},{"key":"2169_CR38","volume-title":"Combination of vitamin E and L-carnitine is superior in protection against isoproterenol-induced cardiac affection: a histopathological evidence","author":"EA Huwait","year":"2018","unstructured":"Huwait EA. Combination of vitamin E and L-carnitine is superior in protection against isoproterenol-induced cardiac affection: a histopathological evidence. Warsz: Folia Morphol; 2018."},{"key":"2169_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jnutbio.2015.10.005","volume":"28","author":"VK Kondreddy","year":"2016","unstructured":"Kondreddy VK, Anikisetty M, Naidu KA. Medium-chain triglycerides and monounsaturated fatty acids potentiate the beneficial effects of fish oil on selected cardiovascular risk factors in rats. J Nutr Biochem. 2016;28:91\u2013102.","journal-title":"J Nutr Biochem"},{"issue":"Suppl 1","key":"2169_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1748-5827.2009.00800.x","volume":"50","author":"J Haggstrom","year":"2009","unstructured":"Haggstrom J, Hoglund K, Borgarelli M. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease. J Small Anim Pract. 2009;50(Suppl 1):25\u201333.","journal-title":"J Small Anim Pract"},{"issue":"4","key":"2169_CR41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cvsm.2010.03.008","volume":"40","author":"M Borgarelli","year":"2010","unstructured":"Borgarelli M, Haggstrom J. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy. Vet Clin North Am Small Anim Pract. 2010;40(4):651\u201363.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"5","key":"2169_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/ajcn\/36.5.950","volume":"36","author":"AC Bach","year":"1982","unstructured":"Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36(5):950\u201362.","journal-title":"Am J Clin Nutr"},{"issue":"14","key":"2169_CR43","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0024-3205(97)01143-0","volume":"62","author":"AA Papamandjaris","year":"1998","unstructured":"Papamandjaris AA, MacDougall DE, Jones PJ. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 1998;62(14):1203\u201315.","journal-title":"Life Sci"},{"issue":"4","key":"2169_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1939-1676.2000.tb02252.x","volume":"14","author":"M Rishniw","year":"2000","unstructured":"Rishniw M, Erb HN. Evaluation of four 2-dimensional echocardiographic methods of assessing left atrial size in dogs. J Vet Intern Med. 2000;14(4):429\u201335.","journal-title":"J Vet Intern Med"},{"issue":"10","key":"2169_CR45","first-page":"2015","volume":"45","author":"CW Lombard","year":"1984","unstructured":"Lombard CW. Normal values of the canine M-mode echocardiogram. Am J Vet Res. 1984;45(10):2015\u20138.","journal-title":"Am J Vet Res"},{"issue":"1","key":"2169_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1939-1676.2007.0008.x","volume":"22","author":"M Borgarelli","year":"2008","unstructured":"Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med. 2008;22(1):120\u20138.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"2169_CR47","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.tvjl.2013.05.040","volume":"197","author":"AM Petit","year":"2013","unstructured":"Petit AM, Gouni V, Tissier R, Trehiou-Sechi E, Misbach C, Pouchelon JL, Lefebvre HP, Chetboul V. Systolic arterial blood pressure in small-breed dogs with degenerative mitral valve disease: a prospective study of 103 cases (2007-2012). Vet J. 2013;197(3):830\u20135.","journal-title":"Vet J"},{"issue":"5","key":"2169_CR48","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1939-1676.2011.0774.x","volume":"25","author":"I Ljungvall","year":"2011","unstructured":"Ljungvall I, Hoglund K, Carnabuci C, Tidholm A, Haggstrom J. Assessment of global and regional left ventricular volume and shape by real-time 3-dimensional echocardiography in dogs with myxomatous mitral valve disease. J Vet Intern Med. 2011;25(5):1036\u201343.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"2169_CR49","first-page":"364","volume":"171","author":"MG Weiser","year":"1977","unstructured":"Weiser MG, Spangler WL, Gribble DH. Blood pressure measurement in the dog. J Am Vet Med Assoc. 1977;171(4):364\u20138.","journal-title":"J Am Vet Med Assoc"},{"issue":"10","key":"2169_CR50","doi-asserted-by":"publisher","first-page":"e1002404","DOI":"10.1371\/journal.pmed.1002404","volume":"14","author":"K Rahimi","year":"2017","unstructured":"Rahimi K, Mohseni H, Otto CM, Conrad N, Tran J, Nazarzadeh M, Woodward M, Dwyer T, MacMahon S. Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017;14(10):e1002404.","journal-title":"PLoS Med"},{"issue":"11","key":"2169_CR51","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2460\/javma.1999.215.11.1623","volume":"215","author":"RL Stepien","year":"1999","unstructured":"Stepien RL, Rapoport GS. Clinical comparison of three methods to measure blood pressure in nonsedated dogs. J Am Vet Med Assoc. 1999;215(11):1623\u20138.","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"2169_CR52","first-page":"211","volume":"70","author":"CE Haberman","year":"2006","unstructured":"Haberman CE, Kang CW, Morgan JD, Brown SA. Evaluation of oscillometric and Doppler ultrasonic methods of indirect blood pressure estimation in conscious dogs. Can J Vet Res. 2006;70(3):211\u20137.","journal-title":"Can J Vet Res"},{"key":"2169_CR53","doi-asserted-by":"crossref","unstructured":"Li Q, Lauber CL, Czarnecki-Maulden G, Pan Y, Hannah SS: Effects of the Dietary Protein and Carbohydrate Ratio on Gut Microbiomes in Dogs of Different Body Conditions. MBio. 2017;8(1).","DOI":"10.1128\/mBio.01703-16"},{"issue":"4","key":"2169_CR54","first-page":"6","volume":"22","author":"DP Laflamme","year":"1997","unstructured":"Laflamme DP. Development and validation of a body condition score system for dogs. Canine Practice. 1997;22(4):6.","journal-title":"Canine Practice"},{"issue":"6","key":"2169_CR55","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","volume":"43","author":"K Hansson","year":"2002","unstructured":"Hansson K, Haggstrom J, Kvart C, Lord P. Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier king Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound. 2002;43(6):568\u201375.","journal-title":"Vet Radiol Ultrasound"},{"key":"2169_CR56","first-page":"311","volume-title":"Textbook of Veterinary Internal Medicine","author":"MC B\u00e9langer","year":"2005","unstructured":"B\u00e9langer MC. Echocardiography. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. 6th ed. St Louis: Elsevier Saunders; 2005. p. 311\u201326.","edition":"6"},{"key":"2169_CR57","first-page":"220","volume-title":"Textbook of Veterinary Internal Medicine","author":"R Prosek","year":"2017","unstructured":"Prosek R. Abnormal heart sounds and heart murmurs. In: Ettinger SJ, Feldman EC, Cote E, editors. Textbook of Veterinary Internal Medicine. 8th ed. St Louis, Missouri: Elsevier; 2017. p. 220\u20134.","edition":"8"},{"issue":"1","key":"2169_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jvc.2011.11.005","volume":"14","author":"V Chetboul","year":"2012","unstructured":"Chetboul V, Tissier R. Echocardiographic assessment of canine degenerative mitral valve disease. J Vet Cardiol. 2012;14(1):127\u201348.","journal-title":"J Vet Cardiol"},{"issue":"2","key":"2169_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1760-2734(06)70050-9","volume":"5","author":"RA Muzzi","year":"2003","unstructured":"Muzzi RA, de Araujo RB, Muzzi LA, Pena JL, Silva EF. Regurgitant jet area by Doppler color flow mapping: quantitative assessment of mitral regurgitation severity in dogs. J Vet Cardiol. 2003;5(2):33\u20138.","journal-title":"J Vet Cardiol"},{"issue":"1","key":"2169_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, Maechler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"},{"issue":"1","key":"2169_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v069.i01","volume":"69","author":"RV Lenth","year":"2016","unstructured":"Lenth RV. Least-squares means: the R package lsmeans. J Stat Softw. 2016;69(1):1\u201333.","journal-title":"J Stat Softw"},{"key":"2169_CR62","unstructured":"Christensen RHB: ordinal - Regression Models for Ordinal Data. R package version 2018. 8-25. 2018."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-2169-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2169-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T16:33:03Z","timestamp":1722097983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-2169-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-2169-1","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Animal Care and Use Committee of the Nestl\u00e9 Purina PetCare Company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"QL, NLM, and BVB are current employees, AH and DPL are paid consultants of the Nestl\u00e9 Purina PetCare Company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"425"}}